Literature DB >> 19747453

L-Serine-O-phosphate in the central nervous system.

Jordan E Antflick1, Sandra Vetiska, Joan S Baizer, Yi Yao, Glen B Baker, David R Hampson.   

Abstract

L-serine-O-phosphate (L-SOP) is the immediate precursor to L-serine in the serine synthesis pathway and is also an agonist at the Group III metabotropic glutamate receptors (mGluRs). L-SOP is produced by the enzyme phosphoserine aminotransferase (PSAT) and metabolized to L-serine by phosphoserine phosphatase (PSP). Using a novel analytical procedure, we show that L-SOP is present in rat whole brain, and that in transfected cells, it is substantially more potent than L-glutamate at the mGluR4 receptor subtype. Immunocytochemical analyses showed that the distributions of PSAT and PSP in the cerebral cortex, hippocampus, and cerebellum were similar in the rat and macaque monkey brain. In the rat hippocampus, cells within the subgranular zone were co-labeled with anti-PSP and anti-PSA-NCAM, a marker for neurogenic cells. In the cerebellar cortex, Purkinje neurons expressed relatively high levels of both enzymes while robust expression of PSAT was also observed in the Bergmann glia. L-SOP released from Purkinje neurons or Bergmann glia could activate mGluR4 present on parallel fiber terminals. The presence of l-SOP in brain, its high potency at mGluR4, together with the restricted distributions of the synthetic and metabolic enzymes, suggest that L-SOP might act activate Group III metabotropic glutamate receptors in the CNS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747453     DOI: 10.1016/j.brainres.2009.08.087

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Selectivity and evolutionary divergence of metabotropic glutamate receptors for endogenous ligands and G proteins coupled to phospholipase C or TRP channels.

Authors:  Hye Jin Kang; Kit Menlove; Jianpeng Ma; Angela Wilkins; Olivier Lichtarge; Theodore G Wensel
Journal:  J Biol Chem       Date:  2014-09-05       Impact factor: 5.157

2.  Drug Design Strategies for GPCR Allosteric Modulators.

Authors:  P Jeffrey Conn; Scott D Kuduk; Darío Doller
Journal:  Annu Rep Med Chem       Date:  2012       Impact factor: 1.059

3.  A novel balanced chromosomal translocation found in subjects with schizophrenia and schizotypal personality disorder: altered l-serine level associated with disruption of PSAT1 gene expression.

Authors:  Yuji Ozeki; Benjamin S Pickard; Shin-ichi Kano; Mary P Malloy; Mariela Zeledon; Daniel Q Sun; Kumiko Fujii; Keiko Wakui; Yukihiko Shirayama; Yoshimitsu Fukushima; Hiroshi Kunugi; Kenji Hashimoto; Walter J Muir; Douglas H Blackwood; Akira Sawa
Journal:  Neurosci Res       Date:  2010-10-16       Impact factor: 3.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.